Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

ISET 2024

Natural Progress of High-Risk CLTI: The CLariTI Study 12-month Results

02/29/2024

Watch as Dr. Anahita Dua, vascular surgeon at Massachusetts General Hospital in Boston, discusses the CLariTI Study, an observational registry that tracked the clinical progression of chronic limb-threatening ischemia and incidence of death, amputation, and revascularization attempts over a 1-year period.


Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Critical Limb-Threatening Ischemia
Reflow Medical Completes Enrollment in the DEEPER REVEAL Clinical Trial
05/08/2024

Reflow Medical News

Reflow Medical News
The prospective, single-arm, multicenter study will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in the infrapopliteal arteries below the knee. A novel device intended for use in patients with...
The prospective, single-arm, multicenter study will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in the infrapopliteal arteries below the knee. A novel device intended for use in patients with...
The prospective, single-arm,...
05/08/2024
Cath Lab Digest
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
Pulmonary Embolism
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
05/07/2024

AngioDynamics Press Release

AngioDynamics Press Release
New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot burden LATHAM, N.Y.--(BUSINESS WIRE)--May...
New data finds AlphaVac F1885 System safe in patients with acute intermediate-risk pulmonary embolism (PE) and provides significant improvement in right ventricular function and reduction in clot burden LATHAM, N.Y.--(BUSINESS WIRE)--May...
New data finds AlphaVac F1885...
05/07/2024
Vascular Disease Management
News
Provisio Medical Announces Physician Advisory Board
05/07/2024

Provisio Medical Press Release

Provisio Medical Press Release ...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery, Interventional Radiology and Interventional Cardiology to Help Guide Commercialization SAN DIEGO, May 6, 2024 /PRNewswire/ -- Provisio Medical, Inc. today announced the formation of a Physician Advisory Board...
Experts in Vascular Surgery,...
05/07/2024
Vascular Disease Management
AAA Endoprosthesis
Now Indicated for AAA Patients With Highly Angulated Necks
05/01/2024

Gore Media Update

Gore Media Update
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30,...
05/01/2024
Vascular Disease Management
STS Valve Calculator
The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators
04/29/2024

The Society of Thoracic Surgeons News

The Society of Thoracic Surgeons News...
To inform heart team and patient decision-making on valve surgery, The Society of Thoracic Surgeons (STS) has launched new risk calculators for isolated tricuspid valve repair and replacement; surgical aortic valve replacement (SAVR) after...
To inform heart team and patient decision-making on valve surgery, The Society of Thoracic Surgeons (STS) has launched new risk calculators for isolated tricuspid valve repair and replacement; surgical aortic valve replacement (SAVR) after...
To inform heart team and patient...
04/29/2024
Cath Lab Digest
Bioresorbable Scaffolds
FDA Approves Abbott's Esprit BTK Everolimus Eluting Resorbable Scaffold System for Chronic Limb-Threatening Ischemia (CLTI) Below the Knee (BTK)
04/29/2024

Abbott News

Abbott News
"The FDA approval of Abbott's Esprit BTK System marks a significant milestone in our fight against peripheral artery disease below the knee and should usher in a new era of improved outcomes for people worldwide," said Sahil A. Parikh, M.D.,...
"The FDA approval of Abbott's Esprit BTK System marks a significant milestone in our fight against peripheral artery disease below the knee and should usher in a new era of improved outcomes for people worldwide," said Sahil A. Parikh, M.D.,...
"The FDA approval of Abbott's...
04/29/2024
Cath Lab Digest
Intravascular Imaging
Provisio Medical Announces FDA Clearance of the Provisio SLT IVUS™ System
04/25/2024

Provisio Medical Press Release

Provisio Medical Press Release ...
Groundbreaking technology for the precise, automatic measurement of peripheral blood vessels to optimize treatment strategies SAN DIEGO, April 25, 2024 /PRNewswire/ -- Provisio Medical today announced FDA 510(k) clearance of the Provisio™...
Groundbreaking technology for the precise, automatic measurement of peripheral blood vessels to optimize treatment strategies SAN DIEGO, April 25, 2024 /PRNewswire/ -- Provisio Medical today announced FDA 510(k) clearance of the Provisio™...
Groundbreaking technology for...
04/25/2024
Vascular Disease Management
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
Venous Disease
New Randomized Controlled Data From Venaseal Spectrum Program Reinforces Evidence That Venaseal™ Closure System Is Safe and Effective
04/24/2024

Medtronic News Alert

Medtronic News Alert
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in...
04/24/2024
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement